ArticleFEBS open bio2024

14K prolactin derived 14-mer antiangiogenic peptide targets bradykinin-/nitric oxide-cGMP-dependent angiogenesis.

Jaeok Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.